Portfolio company scPharmaceuticals was acquired by MannKind Corporation.
scPharmaceuticals specializes in cardiovascular and renal therapies, focusing on late-stage biotech commercialization
scPharmaceuticals specializes in cardiovascular and renal therapies, focusing on late-stage biotech commercialization. They provide tailored solutions for R&D companies seeking to bring their products to market swiftly.